
LeonaBio, Inc.
LONAHealthcare|Biotechnology|US
$4.42
+0.07 (+1.73%)
DCF Value
$15.07
Tangible Book / Share
$7.86
Cash / Share
$11.94
Ownership Breakdown
68.0%
Float
3.9M
Shares Outstanding
2.7M
Float Shares
Major Holders (21)
Combined: 198.0%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Portman David J. | Individual | 25.10% | 3,149,470 | Oct 28, 2026 | 13D/G |
| Sermonix Pharmaceuticals, Inc. | Corporation | 25.10% | 3,149,470 | Oct 28, 2026 | 13D/G |
| Joseph Edelman | Individual | 19.99% | 1,889,403 | Oct 26, 2026 | 13D/G |
| Perceptive Advisors LLC | Investment adviser | 19.99% | 1,889,403 | Oct 26, 2026 | 13D/G |
| Perceptive Life Sciences Master Fund, Ltd. | Corporation | 16.50% | 1,559,647 | Oct 26, 2026 | 13D/G |
| Anders Hove | Individual | 12.10% | 1,492,521 | Aug 20, 2026 | 13D/G |
| Leonard Braden Michael | PN, IN | 7.80% | 3,027,163 | Feb 14, 2025 | 13D/G |
| Daniel Schneeberger | HC, IN | 7.70% | 727,481 | May 15, 2026 | 13D/G |
| ADAR1 Capital Management, LLC | IA, OO | 7.70% | 727,481 | May 15, 2026 | 13D/G |
| BML Investment Partners, L.P. | Partnership | 7.20% | 2,775,885 | Feb 14, 2025 | 13D/G |
| Acorn Capital Advisors GP 2, LLC | Other | 7.00% | 663,763 | Aug 20, 2026 | 13D/G |
| Acorn Bioventures 2, L.P. | Partnership | 7.00% | 663,763 | Aug 20, 2026 | 13D/G |
| Acorn Capital Advisors GP, LLC | Other | 5.10% | 480,653 | Aug 20, 2026 | 13D/G |
| Acorn Bioventures, L.P. | Partnership | 5.10% | 480,653 | Aug 20, 2026 | 13D/G |
| Dr. Jeffrey R. Jay, M.D. | HC, IN | 5.03% | 474,345 | Nov 4, 2026 | 13D/G |
| Great Point Partners, LLC | IA, OO | 5.03% | 474,345 | Nov 4, 2026 | 13D/G |
| Ms. Lillian Nordahl | HC, IN | 5.03% | 474,345 | Nov 4, 2026 | 13D/G |
| Perceptive Xontogeny Venture Fund II, LP | Partnership | 3.80% | 359,837 | Oct 26, 2026 | 13D/G |
| Baselake Partners, LP | Partnership | 1.90% | 75,789 | Feb 6, 2026 | 13D/G |
| Baselake Management, LLC | IA, OO | 1.90% | 75,789 | Feb 6, 2026 | 13D/G |
| David Paolella | HC, IN | 1.90% | 75,789 | Feb 6, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 25,368,755 acquired · 6,365,023 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Portman David J. | 10 percent owner | Oct 26, 2026 | BUY | 3,149,470 | $3149.47 | $9.92B | Form 4 |
| Portman David J. | 10 percent owner | Oct 26, 2026 | BUY | 5,502,402 | $0.00 | $5.5K | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Oct 26, 2026 | OPTION EX. | 776,648 | $0.00 | $776.65 | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Oct 26, 2026 | OPTION EX. | 776,648 | $0.00 | $776.65 | Form 4 |
| Portman David J. | 10 percent owner | Oct 26, 2026 | OTHER | 5,502,402 | $0.00 | $5.5K | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Apr 9, 2026 | AWARD | 28,000 | $9.54 | $267.1K | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Jun 23, 2026 | AWARD | 28,000 | $8.35 | $233.8K | Form 4 |
| Callori Fred | director | Jun 23, 2026 | AWARD | 2,333 | $8.35 | $19.5K | Form 4 |
| Holles Natalie C. | director | Jun 23, 2026 | AWARD | 2,333 | $8.35 | $19.5K | Form 4 |
| Silverman Peter B. | director | Jun 23, 2026 | AWARD | 2,333 | $8.35 | $19.5K | Form 4 |
| Panzara Michael A. | director | Jun 23, 2026 | AWARD | 28,000 | $8.35 | $233.8K | Form 4 |
| Romano Kelly A | director | Jun 23, 2026 | AWARD | 28,000 | $8.35 | $233.8K | Form 4 |
| EDELMAN JOSEPH | director | Jun 23, 2026 | AWARD | 28,000 | $8.35 | $233.8K | Form 4 |
| JOHNSON JAMES A | director | Jun 23, 2026 | AWARD | 28,000 | $8.35 | $233.8K | Form 4 |
| Kosacz Barbara | director | Jun 23, 2026 | AWARD | 28,000 | $8.35 | $233.8K | Form 4 |
| PICKERING GRANT | director | Jun 23, 2026 | AWARD | 28,000 | $8.35 | $233.8K | Form 4 |
| Holles Natalie C. | director | May 5, 2026 | AWARD | 56,000 | $9.63 | $539.3K | Form 4 |
| Silverman Peter B. | director | May 5, 2026 | AWARD | 56,000 | $9.63 | $539.3K | Form 4 |
| Callori Fred | director | May 5, 2026 | AWARD | 56,000 | $9.63 | $539.3K | Form 4 |
| Silverman Peter B. | May 5, 2026 | OTHER | 0 | — | — | Form 4 | |
| Holles Natalie C. | May 5, 2026 | OTHER | 0 | — | — | Form 4 | |
| Callori Fred | May 5, 2026 | OTHER | 0 | — | — | Form 4 | |
| Panzara Michael A. | director | Apr 9, 2026 | AWARD | 28,000 | $9.54 | $267.1K | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Apr 9, 2026 | AWARD | 300,000 | $9.54 | $2.9M | Form 4 |
| Kosacz Barbara | director | Apr 9, 2026 | AWARD | 28,000 | $9.54 | $267.1K | Form 4 |
| PICKERING GRANT | director | Apr 9, 2026 | AWARD | 28,000 | $9.54 | $267.1K | Form 4 |
| Romano Kelly A | director | Apr 9, 2026 | AWARD | 28,000 | $9.54 | $267.1K | Form 4 |
| JOHNSON JAMES A | director | Apr 9, 2026 | AWARD | 28,000 | $9.54 | $267.1K | Form 4 |
| EDELMAN JOSEPH | director | Apr 9, 2026 | AWARD | 28,000 | $9.54 | $267.1K | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Apr 9, 2026 | AWARD | 350,000 | $9.54 | $3.3M | Form 4 |
| FLUKE JOHN M JR | director | Apr 9, 2026 | AWARD | 28,000 | $9.54 | $267.1K | Form 4 |
| Worthington Mark | GENERAL COUNSEL and CCO | Apr 9, 2026 | AWARD | 300,000 | $9.54 | $2.9M | Form 4 |
| Renninger Robert | CHIEF FINANCIAL OFFICER | Apr 9, 2026 | AWARD | 300,000 | $9.54 | $2.9M | Form 4 |
| Litton Mark James | director, officer: PRESIDENT and CEO | Apr 9, 2026 | AWARD | 750,000 | $9.54 | $7.2M | Form 4 |
| Litton Mark James | director, officer: PRESIDENT and CEO | Mar 3, 2026 | OPTION EX. | 22,254 | — | — | Form 4 |
| Litton Mark James | director, officer: PRESIDENT and CEO | Mar 4, 2026 | SELL | 5,156 | $5.37 | $27.7K | Form 4 |
| Litton Mark James | director, officer: PRESIDENT and CEO | Mar 3, 2026 | OPTION EX. | 22,254 | — | — | Form 4 |
| Renninger Robert | CHIEF FINANCIAL OFFICER | Mar 3, 2026 | OPTION EX. | 3,900 | — | — | Form 4 |
| Renninger Robert | CHIEF FINANCIAL OFFICER | Mar 4, 2026 | SELL | 906 | $5.37 | $4.9K | Form 4 |
| Renninger Robert | CHIEF FINANCIAL OFFICER | Mar 3, 2026 | OPTION EX. | 3,900 | — | — | Form 4 |
| Worthington Mark | GENERAL COUNSEL and CCO | Mar 3, 2026 | OPTION EX. | 5,726 | — | — | Form 4 |
| Worthington Mark | GENERAL COUNSEL and CCO | Mar 4, 2026 | SELL | 1,328 | $5.37 | $7.1K | Form 4 |
| Worthington Mark | GENERAL COUNSEL and CCO | Mar 3, 2026 | OPTION EX. | 5,726 | — | — | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Mar 3, 2026 | OPTION EX. | 5,856 | — | — | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Mar 4, 2026 | SELL | 1,359 | $5.37 | $7.3K | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Mar 3, 2026 | OPTION EX. | 5,856 | — | — | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Mar 3, 2026 | OPTION EX. | 7,418 | — | — | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Mar 4, 2026 | SELL | 1,720 | $5.37 | $9.2K | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Mar 3, 2026 | OPTION EX. | 7,418 | — | — | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Dec 31, 2025 | OPTION EX. | 4,667 | — | — | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Jan 2, 2026 | SELL | 1,644 | $6.88 | $11.3K | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Dec 31, 2025 | OPTION EX. | 4,667 | — | — | Form 4 |
| Litton Mark James | director, officer: President and CEO | Dec 31, 2025 | OPTION EX. | 10,834 | — | — | Form 4 |
| Litton Mark James | director, officer: President and CEO | Jan 2, 2026 | SELL | 2,586 | $6.88 | $17.8K | Form 4 |
| Litton Mark James | director, officer: President and CEO | Dec 31, 2025 | OPTION EX. | 10,834 | — | — | Form 4 |
| Renninger Robert | Chief Financial Officer | Dec 31, 2025 | OPTION EX. | 1,236 | — | — | Form 4 |
| Renninger Robert | Chief Financial Officer | Jan 2, 2026 | SELL | 297 | $6.88 | $2.0K | Form 4 |
| Renninger Robert | Chief Financial Officer | Nov 18, 2025 | AWARD | 1,000 | $2.31 | $2.3K | Form 4 |
| Renninger Robert | Chief Financial Officer | Dec 31, 2025 | OPTION EX. | 1,236 | — | — | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Dec 31, 2025 | OPTION EX. | 3,667 | — | — | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Jan 2, 2026 | SELL | 876 | $6.88 | $6.0K | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Nov 18, 2025 | AWARD | 1,000 | $2.31 | $2.3K | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Dec 31, 2025 | OPTION EX. | 3,667 | — | — | Form 4 |
| Worthington Mark | General Counsel and CCO | Dec 31, 2025 | OPTION EX. | 3,667 | — | — | Form 4 |
| Worthington Mark | General Counsel and CCO | Jan 2, 2026 | SELL | 876 | $6.88 | $6.0K | Form 4 |
| Worthington Mark | General Counsel and CCO | Dec 31, 2025 | OPTION EX. | 3,667 | — | — | Form 4 |
| Renninger Robert | Chief Financial Officer | Dec 24, 2025 | AWARD | 34,358 | $4.07 | $139.8K | Form 4 |
| Litton Mark James | director, officer: President and CEO | Dec 24, 2025 | AWARD | 133,526 | $3.81 | $508.7K | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Dec 24, 2025 | AWARD | 35,138 | $4.07 | $143.0K | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Dec 24, 2025 | AWARD | 44,508 | $4.07 | $181.1K | Form 4 |
| Worthington Mark | General Counsel and CCO | Dec 24, 2025 | AWARD | 34,358 | $4.07 | $139.8K | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Dec 23, 2025 | AWARD | 5,502,402 | $0.00 | $5.5K | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Dec 23, 2025 | AWARD | 3,838,583 | $6.35 | $24.4M | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Dec 23, 2025 | AWARD | 3,543,307 | $7.62 | $27.0M | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Dec 23, 2025 | AWARD | 989,270 | $6.35 | $6.3M | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Dec 23, 2025 | AWARD | 1,372,935 | $0.00 | $1.4K | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Dec 23, 2025 | AWARD | 1,279,526 | $6.35 | $8.1M | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Dec 23, 2025 | AWARD | 1,181,101 | $7.62 | $9.0M | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Dec 23, 2025 | AWARD | 457,645 | $0.00 | $457.64 | Form 4 |
| PERCEPTIVE ADVISORS LLC | director, 10 percent owner: | Dec 23, 2025 | AWARD | 329,756 | $6.35 | $2.1M | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Jun 30, 2025 | OPTION EX. | 36,666 | — | — | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Jul 1, 2025 | SELL | 8,526 | $0.29 | $2.5K | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | May 19, 2025 | AWARD | 10,000 | $0.23 | $2.3K | Form 4 |
| CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | Jun 30, 2025 | OPTION EX. | 36,666 | — | — | Form 4 |
| Litton Mark James | director, officer: President and CEO | Jun 30, 2025 | OPTION EX. | 108,334 | — | — | Form 4 |
| Litton Mark James | director, officer: President and CEO | Jul 1, 2025 | SELL | 25,123 | $0.29 | $7.4K | Form 4 |
| Litton Mark James | director, officer: President and CEO | Jun 30, 2025 | OPTION EX. | 108,334 | — | — | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Jun 30, 2025 | OPTION EX. | 46,666 | — | — | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Jul 1, 2025 | SELL | 10,842 | $0.29 | $3.2K | Form 4 |
| San Martin Javier | CHIEF MEDICAL OFFICER | Jun 30, 2025 | OPTION EX. | 46,666 | — | — | Form 4 |
| Worthington Mark | General Counsel and CCO | Jun 30, 2025 | OPTION EX. | 36,666 | — | — | Form 4 |
| Worthington Mark | General Counsel and CCO | Jul 1, 2025 | SELL | 8,526 | $0.29 | $2.5K | Form 4 |
| Worthington Mark | General Counsel and CCO | Jun 30, 2025 | OPTION EX. | 36,666 | — | — | Form 4 |
| Renninger Robert | SVP, Finance and Accounting | Jun 30, 2025 | OPTION EX. | 12,359 | — | — | Form 4 |
| Renninger Robert | SVP, Finance and Accounting | Jul 1, 2025 | SELL | 2,897 | $0.29 | $850.27 | Form 4 |
| Renninger Robert | SVP, Finance and Accounting | May 19, 2025 | AWARD | 10,000 | $0.23 | $2.3K | Form 4 |
| Renninger Robert | SVP, Finance and Accounting | Jun 30, 2025 | OPTION EX. | 12,359 | — | — | Form 4 |
| FLUKE JOHN M JR | director | May 30, 2025 | AWARD | 20,900 | $0.31 | $6.5K | Form 4 |
| Panzara Michael A. | director | May 30, 2025 | AWARD | 20,900 | $0.31 | $6.5K | Form 4 |
| Romano Kelly A | director | May 30, 2025 | AWARD | 20,900 | $0.31 | $6.5K | Form 4 |